Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The pandemic is testing our societal structures like never before. To deal with it successfully, we need to think and act collectively, led by our key institutions. But at a time when unity is critical, are we about to see the effects of a long-standing and corrosive drip feed of mistrust?

Nurse discussing vaccination with female patient

The rapid development and testing of COVID-19 vaccines has been an extraordinary scientific undertaking. What happens now is arguably even more important: to ensure the vaccines are an effective intervention, people will need to take them. The practical challenges of manufacturing and dispensing millions of doses worldwide are of course immense, but societies also have to deal with the issue of vaccine hesitancy: the belief that a vaccine may be unnecessary, ineffective, or unsafe (and perhaps all three). Unsurprisingly, people who have these concerns may be reluctant to take a vaccine; they may even refuse it outright.

Vaccine hesitancy isn’t new. However, the pandemic has created the ideal conditions for mistrust of a COVID-19 vaccine to thrive. Part of the problem is the complexity and variability of transmission and infection. The fact that you may not catch the virus if you break social distancing guidelines and that the illness may be mild if you do get it, has led some to conclude that there isn’t a real problem. The unprecedented speed with which the vaccines have been developed has also provoked worry: there are concerns that safety has been compromised or that the vaccine will be rolled out before we understand the extent and nature of possible side effects. Moreover, the Internet is awash with misinformation -- including conspiracy theories – about the virus, lockdown, and vaccinations.

Read the full blog on the University of Oxford website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.